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1. Introduction
   In drug discovery and development, medicinal herbs 
have consistently been considered the leading source of 
pharmaceuticals, employed in the treatment of various 
human diseases due to their high chemical diversity and 
broad biological functionality[1]. 
  Diabetes mellitus and obesity remains the most 
common disorders of carbohydrate metabolism. Diabetes 
mellitus is a metabolic disorder of multiple etiologies 
characterized by chronic hyperglycaemia with disturbance 
of carbohydrate, fat and protein metabolism resulting from 
defects in insulin secretion, insulin action or both[2]. 
   It affected about 171 million people worldwide in 2000 
and the number is projected to increase to at least 366 
million by 2030[3]. One therapeutic approach for treating 
diabetes is to decrease the post-prandial hyperglycaemia. 
This is done by inhibiting the glucose absorption at the 
small intestine[4-6].
   Plants continue to play an important role in the treatment 
of diabetes. The increase in demand in industrially-
developed countries to use alternative approaches to treat 
diabetes, such as plant-based medicines, is also due to 
the side effects associated with the use of insulin and oral 
hypoglycaemic agents[7]. More than 400 plants are being 
used in different forms to treat diabetes[8]. There are more 
than 200 pure compounds from plant sources that have 
been reported to show blood glucose lowering activity[7]. 
The wide variety of chemicals classes indicates that a 
variety of mechanisms of action are likely to be involved 
in lowering blood glucose levels. In this study, P. amarus 
Schum was selected on the basis of their use in traditional 
medicines throughout Southeast Asia and experimentally 
determined its hypoglycaemic activity in-vivo. 
  Extracts of this species was tested for its inhibition 
effect on glucose transport across the rat gut in-vivo and 
ex-vivo (everted gut sacs). P. amarus Schum (Family: 
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Euphorbiaceae) is a widely distributed small erect, tropical 
annual herbal shrub whose stem has green capsule. 
   The seeds are longitudinally rogues[8]. It is found in 
parts of South India, Florida, Mexico and throughout 
Southern America[9]. P. amarus locally known as Keela 
Nelli. P.amarus has been reported to have several 
pharmacological activities. 
   Some of the other properties of this plant might exert 
beneficial effects during diabetes in addition to the 
glucose absorption inhibition reported in the present study. 
Antioxidant activity[10], lipid lowering activity[11] and anti-
inflammatory effect[12], may all play a part in the treatment 
of the various pathogenic effects of diabetes. 
   The present study is undertaken to estimate the glucose 
uptake inhibition activity of P. amarus aqueous leaf extract 
across the rat gut in-vivo and everted rat gut sacs ex-vivo.
2. Materials and methods
2.1. Animals
   Male albino rats of Wistar strain weighing around 160-180 
g were procured from Tamilnadu Veterinary and Animal 
Sciences University, Chennai. The animals were kept in 
polypropylene cages (three in each cage) at an ambient 
temperature of (25依2) 曟 and 55%-65% relative humidity. 
A 12/12 h light and dark schedule was maintained in 
the animal house and animals were acclimatized to the 
laboratory conditions, fed with commercially available rat 
chow (Hindustan Lever Ltd., Bangalore, India) and had free 
access to water.
2.2. Plant material
   The P. amarus (Family: Euphorbiaceae) leaves were 
collected from Vellore District of Tamilnadu, India 
during August to October, 2009. The leaves were cleaned, 
shade dried, authenticated and a voucher specimen (No: 
VCV/43/2009) is kept at the Department of Botany, Voorhees 
College, Vellore - 632 001, Tamilnadu, India.
2.3. Plant extracts preparation
   Fresh leaves were washed with distilled water and 
shade dried. The shade dried leaves were powdered in an 
electrical blender and stored at 5 曟 until further use. The 
powdered leaves were taken 100 g each and mixed with 200 
mL of distilled water and were stirred magnetically at room 
temperature. The residue was removed by filtration and the 
aqueous extracts were used for experiments.  
2.4. Hypoglycemic studies
   Hypoglycemic studies were conducted in male albino 
rats as described earlier[13,14]. The studies were conducted 
in two animal models. Glucose loaded rat model and 
diabetic rat models.
2.5. Glucose loaded model
   Plant extracts were fed to the fasted rats. After half an 
hour interval 10% glucose solution (1.5 g/kg body weight) 
was fed by oral administration and blood glucose samples 
were collected for glucose estimation at I, III and IV hours 
of interval.
2.6. Diabetic model
   The animals were subjected to fasting overnight and 
diabetes was induced by a single intra peritoneal injection 
of freshly prepared solution of streptozotocin (Sigma, USA) 
35 mg/kg body weight in 0.1 M cold citrate buffer of pH 4.5. 
Streptozotocin (STZ) was used to induce diabetes in animals 
by various authors[15-17]. 
   The animals were allowed to drink 5% glucose solution 
overnight to bring-on the drug induced hypoglycemia, 
control rats were administered with citrate buffer alone. 
The animals were considered diabetic if the blood glucose 
values were above 250 mg/dL on the third day after STZ 
injection.
2.7. Ex-vivo everted gut sac preparation to study glucose 
absorption inhibition
   The everted rat gut sacs were prepared according to the 
method described by Wilson and Wiseman[18].
2.8. Experimental design and surgical procedure
   Adult male Swiss albino rats weighing 160-180 g 
were housed at room temperature and were used in this 
experiment. Before each experiment, the animals were 
starved for twelve hours but allowed for tap water use. Rats 
were sacrificed by cervical dislocation. The abdomen was 
opened by a midline incision. The entire small intestine 
was removed quickly by cutting across the upper end of 
the duodenum and the lower end of the ileum, and by 
stripping the mesentery manually. The small intestine was 
then washed with normal saline solution (0.9% w/v NaCl) 
using a syringe equipped with blunt end.
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2.9. Preparation of everted gut sacs
   Intestinal segments (10依2) cm were everted and the sacs 
were filled with 0.5 mL of the incubation medium (serosal 
fluid) and were placed in 25 mL Erlenmeyer flasks with 5 mL
of the same medium (mucosal fluid). After oxygenation 
of the flasks with 100% O2 for 1 min, they were tightly 
stoppered and kept in a shaker (90-110 oscillations/min) 
for 1 h at room temperature. The incubation medium 
was Krebs-Henseleit Bicarbonate buffer (KHB). The 
composition of the buffer was (mM/L): NaHCO3 25; NaCl 
118; KCl 4.7; MgSO4 1.2; CaCl2 1.2; and Na2EDTA 9.7 mg/L. 
Glucose (5.5-8.5 mM) was added to the medium just before 
the start of appropriate experiment.
2.10. Evaluation of intestinal glucose uptake under the 
influence of plant extracts.
   For studying the effect of the plant extract on glucose 
(substrate) uptake, glucose was added into mucosal 
compartment fluid just before the start of the experiment. 
The aqueous leaf extract was also added in the same 
compartment (3.62 mg/mL). At the end of the incubation 
period (1 h), the sacs were removed from the flask and 
these sacs were emptied and the serosal fluid from the sacs 
was used for the estimation of glucose. Similar estimations 
were also performed on samples of mucosal fluid in the 
flasks. Glucose concentrations were measured using a 
commercially available glucose oxidase kit (Lifechem TM 
-Glucose-LR). The loss of glucose from the mucosal fluid 
assumed to represent the glucose taken up by the intestine, 
and the rise in glucose in serosal fluid, the glucose 
released. The difference is attributable to the glucose 
retained in the tissue. The amount of glucose transported 
from the mucosal compartment was characterized as 
“Uptake” while the serosal gain of the substances is 
treated as “release”. Uptake and release of glucose was 
expressed as PM/g tissue wet weight/h.
2.11. Kinetic study on ex-vivo glucose uptake
   A kinetic study was conducted to understand the 
transport/inhibition of glucose across intestinal membrane. 
In terms of enzyme kinetics, the amount of glucose 
transported/hour was analogue to the velocity of transfer, 
in other words, to the concentration difference of the 
glucose between compartments at the beginning and end of 
an experiment[5]. 
   The Michaelis-Menten constant (Km), which is the affinity 
of the transferring enzyme (glucose transporter) for the 
substrate (glucose). The maximal velocity (Vmax), which 
is the rate of transfer reaction in the presence as well 
as in the absence of the plant extracts were determined 
from the differences of the uptake and release values 
using Michelis-Menten and the Lineweaver-Burk Plots 
in Microsoft excel. Comparison of difference between the 
control and experimental groups were examined using 
one-way analysis of variance (ANOVA). In each series of 
experiments, control everted gut sacs derived from the 
same rat in a buffer containing no substrate(glucose) were 
run in parallel. The controls were run either with or without 
plant extract and results were corrected accordingly.
2.12. Statistical analysis
   The results were expressed in mean + standard deviation. 
Statistical analysis was carried out by using one way 
ANOVA as in standard statistical software package of 
social science (SPSS) version 12.
3. Results
Table 1. 
Hypoglycemic effect of aqueous leaf extract of traditional medicinal plant P. 
amarus: a) Glucose loaded model; b) Streptozotocin (STZ) induced diabetic 
model-Levels of blood glucose at I, III and IV hour of intervals.
a) Glucose loaded model
Normal (n) Control (C)
Experimental groups
I h III h IV h
78.00依1.09 110.00依1.89 101.00依2.77* 74.00依8.98* 65.00依7.62*
b) STZ induced diabetic model
Normal  (n)  Diabetic control (DC)
Experimental groups
I h  III h IV h
78.00依2.09 389.00依5.69 290.00依10.48*  257.00依5.09*  175.00依9.45*
Data are expressed as Mean 依 SD of 6 individual observations. Values are 
expressed as mean 依 SD of six experiments. *P<0.000 1.
Table 2.
Effects of P. amarus aqueous leaf extract on the uptake of the varying 




Uptake (毺mol/g tissue 
wet wt/h) Control (n=6) 
Uptake (毺mol/g tissue wet medium 
he P. amarus (3.62 mg/mL) (n=6)  
5.5   45.45 依 4.42 37.03 依 2.42*
6.5   57.14 依 2.60 40.00 依 1.37*
7.5   68.96 依 3.23 47.00 依 1.59*
8.5                    100.00 依 2.53 68.96 依 2.51*
The gut sacs were incubated in Kerbs-henseleit buffer (pH=7.4) at 37 曟. 
Values are expressed as mean 依 SD of six experiments.  *P<0.000 1. 
n=number of sacs used. 
Table 3. 
Effect of P. amarus aqueous leaf extract: Kinetic parameters of the transport of 
D-glucose at different concentrations (5.5-8.5) across the rat everted gut sacs.
Experiments Vmax (mM/h) Km (mM)
Control (n=6) 0.125 20.83
P. amarus (3.62 mg/mL) (n=6)         0.071 20.53             
Km and Vmax values were obtained from Line weaver-Burk Plot.
Km: Michaelis-Menton constant, which is the affinity of the transferring 
enzyme for the substrate. Vmax: Maximal velocity, which is the rate of transfer 
reaction, in the presence as well as in the absence of P. amarus aqueous leaf 
extract determined from the differences of uptake and release values using 
Michaelis-Menten and Lineweaver-Burk Plots in Microsoft Excel. 
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   A significant elevation of blood glucose level was 
recorded in the glucose loaded group when compared to 
that of normal. The results revealed a significant blood 
glucose lowering effect in the P. amarus leaf extract 
(250 mg/kg body weight) administered group at I hour, 
III hour and IV hour intervals when compared with that 
of the control (Table 1a). After 48 h of the injection of 
STZ to the normal rats diabetes was evidenced. 
   The blood glucose level was significantly elevated 
in the STZ injected rats when compared to that of 
normal (placebo) and therefore considered as diabetic 
animals (Control). The plant extract administered 
diabetic animals recorded a significant blood glucose 
lowering effect at I h, III and IV h intervals (Table 1b). 
Incubation of the rat everted gut sacs with the aqueous 
extracts of P. amarus at concentration 3.62 mg/mL 
resulted in the inhibition of transport of glucose. The 
glucose transport inhibition was significant at varied 
concentrations i.e. 5.5, 6.5, 7.5 and 8.5 mM/L in the 
incubation medium (Table 2). The pattern of glucose 
uptake ex-vivo in various experimental protocols was 
analyzed using Michelis-Menten and Lineweaver-Burk 
Plots. 
    The Km (Michaelis-Menton constant, which is the 
affinity of the transferring enzyme for the substrate). Vmax 
(Maximal velocity, which is the rate of transfer reaction, 
in the presence as well as in the absence of aqueous 
leaf extract was determined from the differences of 
uptake and release values using Michaelis-Menten and 
Lineweaver-Burk Plots in Microsoft Excel) as single 
entities. 
     The value of Vmax was significantly depleted in the 
entire experimental samples incubated along with the 
plant extract when compared with the control. However 
the Km remained constant throughout the study (Table 
3).
4. Discussion
   The most challenging goal in the management of 
diabetes mellitus is to achieve blood glucose level 
as close to normal as possible. The importance of 
postprandial glucose control in the development of 
diabetic complications is widely recognized based on 
the direct stimulation of endothelial cells by glucose, 
supports the hypothesis that postprandial glucose 
spikes are important in the early development of both 
microvascular and macrovascular diseases[19]. 
   The hypoglycemic studies on the aqueous leaf extract 
of traditional medicinal plant P. amarus revealed 
significant hypoglycemic effect in the glucose loaded 
as well as STZ induced diabetic rat models.  The 
glucose lowering effect of the plant extract in the 
present study might be attributed to delayed intestinal 
glucose absorption and/or increased glucose utilization 
by the intestine with reference to anaerobic glucose 
metabolism thereby creating decreased passage 
of glucose from mucosal side to serosal side of the 
intestine. 
  Further studies were designed to understand the 
intestinal glucose uptake both in the presence and 
absence of the plant extract. The results obtained in 
the present ex vivo study envisaged that the aqueous 
leaf extract of P. amarus significantly inhibits glucose 
absorption/transport in the everted rat gut and 
significantly reduced when compared to control.  
   The Michelis-Menten constant (Km) of the glucose 
uptake was calculated for all the experiments. Km is 
the affinity of the transferring enzyme for the substrate. 
In the present study it is simulated that Km is the 
affinity of glucose transporters i.e. GLUT2 and SGLT1 
for glucose. 
   The maximal velocity (Vmax) is regarded as the glucose 
uptake rate in the presence as well as in the absence of 
plant extract. The decrease in the Vmax in the presence 
of the aqueous extract of the studied plant extract 
indicated that the transmembranal glucose transport 
was significantly decreased. However the Km remained 
unaltered in the presence as well as in the absence 
of the extract. This indicates that the aqueous plant 
extract of P. amarus act by bringing a non-competitive 
type of inhibition of transport of glucose at the level 
of small intestine. This might be due to the inhibition 
of glucose transporter proteins (GLUT2 and SGLT1) 
activity. Previous studies in our lab[6], recorded that the 
aqueous seed extract of Trigonella foenum-graecum 
(T. foenum graecum) inhibited the glucose absorption 
in rat everted gut sacs and studies elsewhere recorded 
that the aqueous extracts of T. foenum graecum (seed) 
and Eugenia jambolana (seed) decreases the glucose 
absorption in rat everted gut sacs[20]. 
  Inhibition of intestinal and renal Na+-glucose co-
transporter by naringenin. The aqueous extract of 
Momordica charantia inhibited the glucose transported 
across the rat everted gut sacs in-vitro[4]. Nigella sativa 
inhibits intestinal glucose absorption and improve 
glucose tolerance in rats[21]. Oral administration of 
aporphines and secoaporphines had an inhibitory effect 
on intestinal glucose uptake[22]. The above studies in 
our lab revealed that the aqueous extract of traditional 
medicinal plant, P. amarus contain phytochemical 
constituents that are potent to inhibit the glucose 
uptake across intestinal membrane which might 
be due to decreased activity of glucose transporter 
transmembranal proteins in the small intestine of 
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rat and thereby opening new scope for postprandial 
glycemic control.
   Based on the data obtained in the present study 
we propose that P. amarus aqueous leaf extract 
possesses hypoglycemic property that inhibits the 
glucose transport at the site of intestinal brush border 
membrane in rats.
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